Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University|December 26, 2024
[Holliday junction-recognizing protein is a potential predictive and prognostic biomarker for kidney renal clear cell carcinoma]Huahua Zhang, Qingyin Ta, Yun Feng, et al.
Clinical Drug Investigation|April 20, 2021
Cost-effectiveness Analysis of Trastuzumab Emtansine as Second-line Therapy for HER2-Positive Breast Cancer in ChinaHuahua Zhang, Yandong Zhang, Chaonan Huang, et al.
International Journal of Clinical Pharmacy|April 23, 2025
Pancreatitis associated with BRAF inhibitors: a disproportionality analysis based on the Food and Drug Administration Adverse Event Reporting SystemShoujun Wang, Jinjing Wang, Huahua Zhang, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|July 7, 2025
HER2-targeted agents and interstitial lung disease: A real-world pharmacovigilance analysis using FAERS dataHuahua Zhang, Yandong Zhang, Xiaoying Wang, et al.
Future Oncology (London, England)|September 20, 2024
Cost-effectiveness of aumolertinib as first-line treatment for EGFR-mutated advanced nonsmall-cell lung cancerHuahua Zhang, Xiaochun Zheng, Yandong Zhang, et al.
Acta Biochimica Et Biophysica Sinica|May 20, 2022
Positive allosteric regulation of PAC1-R up-regulates PAC1-R and its specific ligand PACAPGuangchun Fan, Zhengxin Tao, Shang Chen, et al.
Acta Biochimica Et Biophysica Sinica|September 9, 2022
A novel small positive allosteric modulator of neuropeptide receptor PAC1-R exerts neuroprotective effects in MPTP mouse Parkinson's disease modelGuangchun Fan, Shang Chen, Zhengxin Tao, et al.
Pageof 6